Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 14011
Country/Region: Kenya
Year: 2012
Main Partner: Deloitte Consulting Limited
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $0

The Kenya Medical Supplies Agency (KEMSA) Support Program (KSP) works toward two main objectives: 1) a strong, efficient, effective and accountable KEMSA with regard to its commodity procurement, warehousing and distribution role; and 2) a unified, integrated, responsive and sustainable national supply chain management system. These objectives support overall health systems strengthening to ultimately improve the health status of Kenyans and to develop the capacity of the national supply chain system for effective provision to client health facilities throughout Kenya. KSP specifically addresses improving KEMSAs capacity in procurement, receiving, warehousing, distribution, and reporting on health commodities and equipment. KEMSAs overall organizational capacity to sustainably support the national supply chain is also supported by KSP's efforts to improve leadership and governance among KEMSAs Board, performance monitoring and measurement within the organization, and strengthen its operational mandate. This mechanism maps specifically to Objective 1.4.2 under the Partnership Framework Health Sector HIV Service Delivery Pillar: Commodity and supply chain distribution systems strengthened from national to service delivery levels.KSP supports KEMSA to strengthen the national supply chain and integrate HIV commodities and equipment from parallel programs, transitioning to one unified point of procurement, warehousing, distribution, and reporting on these commodities to increase efficiencies. Transition of responsibility supports the move from parallel HIV supply chain systems to an integrated, national supply chain and works to streamline the existing parallel supply chains. This activity supports GHI/LLC and is competely funded by pipeline funds in this budget cycle.

Global Fund / Programmatic Engagement Questions

1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? Yes2. Is this partner also a Global Fund principal or sub-recipient? Sub Recipient3. What activities does this partner undertake to support global fund implementation or governance?

Budget Code Recipient(s) of Support Approximate Budget Brief Description of ActivitiesOHSS KEMSA 0 KEMSA is the procurement agent for GF Round 10 commodities. KEMSA also supports distribution to the facility level for GF commodities.

Funding for Laboratory Infrastructure (HLAB): $0

Strengthening the laboratory system in Kenya is a critical component of improving the health system. The KEMSA Support Program (KSP) supports the vision of an efficient and effective national lab system to support delivery of quality laboratory services. Specific areas of KSP support include assisting KEMSA to: document and improve business process flows to strengthen quality assurance procedures, develop a procurement plan for laboratory equipment focused on quality assurance within KEMSA, and establish a training approach and curriculum to build the capacity of KEMSA staff in quality assurance. These quality assurance activities are closely monitored by KSP advisors. The KSP team collaborates with KEMSA and other laboratory stakeholders in country including the National Quality Control Laboratory to facilitate an integrated and strengthened national laboratory system.

Funding for Health Systems Strengthening (OHSS): $0

In order to achieve Objective 1.4.2 under the Partnership Framework Pillar 1 Health Sector HIV Service Delivery Commodity and supply chain distribution systems strengthened from national to service delivery levels it is necessary to strengthen the commodity management system at the Kenya Medical Supplies Agency (KEMSA) for effective service provision to client health facilities throughout Kenya. The KEMSA Support Program (KSP) will support KEMSA to strengthen its ability to timely provide client sites throughout Kenya with accurate quantities of quality commodities for effective service provision.A stronger national supply chain will enable facilities to provide improved care through increased access to quality commodities and supplies. In this way, improvements in the national supply chain translate to improvements across other components of the health system. KSP will support KEMSA to strengthen the national supply chain and integrate HIV commodities and equipment from parallel programs, transitioning to one unified system of procurement, warehousing, distribution, and reporting on these commodities to increase efficiencies. Accordingly, KSP works to strengthen these areas through improved business processes, updated systems and infrastructure, skills building and improved institutional capacity and mandate.KSP activities in distribution planning and the creation of action plans for increased pull distribution and rapid test kit (RTK) readiness will prepare KEMSA to manage HIV commodities. A root cause analysis of the RTK planning process will be further investigated to determine the optimal path for push to pull transformation for these and related items. Expired commodities due to excess inventory, possibly driven by redundant procurements of the same commodity from multiple funding programs/agents (a common characteristic of ineffective supply chain planning) will also be addressed.KSP works in collaboration with KEMSA counterparts, existing supply chain projects in Kenya and government stakeholders to ensure that USG and national resources are used most efficiently and to avoid duplication of efforts across programs. This cooperation also builds off of industry best practices and program lessons and progresses the integration of parallel supply chain systems into one national system for HIV commodities.

Funding for Treatment: ARV Drugs (HTXD): $0

The mandate of the Kenya Medical Supplies Agency (KEMSA) is to improve the health of Kenyans through the efficient procurement, warehousing and distribution of health commodities to public health facilities throughout Kenya. To support KEMSA in achieving this mandate, the KEMSA Support Program (KSP) works strategically to strengthen the procurement planning processes across commodities covered by KEMSA including: drugs for opportunistic infections, anti-malarial drugs, and long lasting insecticide treated nets. KSP is assisting KEMSA to plan for rapid test kit (RTK) readiness as KEMSA prepares to manage HIV commodities in FY 12.

KSP provides technical assistance to KEMSA to strengthen its policies, procedures and planning for procurement to promote increased procurement transparency and accountability. In collaboration with KEMSA, KSP advisors assist in procurement strategic planning through participation in national quantification exercises and by contributing to the discussion and analysis of estimates of costs of proposed ART guideline changes and the implications of these changes. Although KEMSA has experienced stock outs last year, KEMSAs systems and operations have been strengthened in the areas of procurement planning and policies. In addition, KEMSA is supporting the push to pull transformation of health facilities in FY 12 which is anticipated to ultimately reduce stock outs nationally and strengthen the overall health system in Kenya.

Subpartners Total: $0
Deloitte Consulting Limited: NA
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning